Ginkgo Bioworks Holdings, Inc. — Form 8-K Summary
Business context and reporting period
Soaring Eagle Acquisition Corp. filed this Form 8-K on September 14, 2021, reporting the results of its extraordinary general meeting of shareholders. The company was pursuing a business combination with Ginkgo Bioworks, Inc. The filing reports shareholder approvals; it does not state that the transaction had closed as of the filing date.
Key financial and corporate metrics
- 162,356,351 shares, representing approximately 75% of issued and outstanding shares as of the August 10, 2021 record date, were present in person or by proxy, establishing a quorum.
- The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, transaction valuation, PIPE proceeds, or other operating financial metrics.
- The proposed post-transaction charter would authorize 16.0 billion shares, including 15.8 billion common shares and 200 million preferred shares.
- The proposed capital structure includes Class A common stock with one vote per share, Class B common stock with 10 votes per share, and generally non-voting Class C common stock.
Material changes and shareholder approvals
All proposals presented at the special meeting were approved, including:
- The business combination agreement with Ginkgo Bioworks, Inc., under which Soaring Eagle would domesticate as a Delaware corporation and a subsidiary would merge with Ginkgo, with Ginkgo surviving as a wholly owned subsidiary.
- Domestication from the Cayman Islands to Delaware.
- Adoption of new charter and bylaws, including changes to authorized capital, voting rights, director nomination rights, exclusive-forum provisions, and removal of blank-check-company provisions.
- Changing the corporate name to Ginkgo Bioworks Holdings, Inc. upon closing.
- Election of seven directors, subject to the transaction conditions.
- Issuance of shares in connection with the merger and a private placement to PIPE investors. The filing does not provide the number of shares or proceeds.
- Approval of the 2021 Incentive Award Plan and 2021 Employee Stock Purchase Plan.
The business combination proposal passed with 157,616,275 votes for, 4,686,874 against, and 53,202 abstentions. The stock issuance proposal passed with 157,119,733 votes for, 4,710,801 against, and 525,817 abstentions.
Guidance, outlook, risks, contingencies, and unusual items
- No financial guidance or operating outlook was provided.
- Completion remained subject to the conditions in the merger agreement and other transaction requirements; shareholder approval alone did not establish that closing had occurred.
- The proposed 10-votes-per-share Class B structure and Class B rights to nominate and elect one-quarter of the board, while Class B shares represent at least 2% of common stock, could concentrate voting and governance influence.
- The proposed charter would authorize a substantially larger share base than the existing charter, creating potential future dilution depending on issuance activity.
- The filing notes an exclusive Delaware forum for certain stockholder litigation and federal court forum for certain other claims, unless the company consents to another forum.
Important facts for investors to verify
- Whether and when the merger, domestication, name change, and Nasdaq listing changes were completed.
- The final transaction valuation, capitalization, share counts, PIPE size and proceeds, and any redemptions.
- The post-closing ownership and voting control associated with Class A, Class B, and Class C shares.
- The final board composition and the operating terms and share reserves of the incentive and employee stock purchase plans.
- Subsequent filings containing Ginkgo’s financial results, cash position, debt, liquidity, and management guidance, which are not included in this 8-K.